Pharmaceuticals: Market Research Report
The global outlook series on Pharmaceuticals provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings.
Punctuated with 46 statistically rich tables, the report provides an overview of the pharmaceutical industry, and highlights global trends impacting the marketplace, such as patent expiry of blockbuster global drugs, increasing biogenerics, among others.
The report offers an in-depth analysis of the pharmaceutical industry, highlights latest trends and demand drivers, the recent FDA approvals, the current and the impending patent expiries, in addition to providing statistical insights.
The report also recapitulates recent noteworthy mergers, acquisitions, and other strategic developments.
The report briefly discusses the pharmaceutical market outlook across various markets worldwide.
Regional markets extensively discussed in the report include the United States, Canada, Japan, China, Germany, South Korea and India, among several others.
Also included is an indexed, easy-to-refer, fact-finder directory listing the addresses, and contact details of 2,589 companies worldwide.
Punctuated with 46 statistically rich tables, the report provides an overview of the pharmaceutical industry, and highlights global trends impacting the marketplace, such as patent expiry of blockbuster global drugs, increasing biogenerics, among others.
The report offers an in-depth analysis of the pharmaceutical industry, highlights latest trends and demand drivers, the recent FDA approvals, the current and the impending patent expiries, in addition to providing statistical insights.
The report also recapitulates recent noteworthy mergers, acquisitions, and other strategic developments.
The report briefly discusses the pharmaceutical market outlook across various markets worldwide.
Regional markets extensively discussed in the report include the United States, Canada, Japan, China, Germany, South Korea and India, among several others.
Also included is an indexed, easy-to-refer, fact-finder directory listing the addresses, and contact details of 2,589 companies worldwide.
1.GLOBAL OUTLOOK
Global Pharmaceutical Market – Hit, but Not Down
Cost Containment and Patent Expirations Affect Market Growth
Industry Seeks Measures to Sustain Future Growth
Outlook Remains Positive, Yet Tempered
Oncologics – The Largest Drug Class in the Global Prescription Pharmaceutical Market
Major Challenges Faced by the Global Pharma Industry
Key Opportunities
Generic Drug Sales Soar
Authorized Generics – A Major Concern for Generic Makers
Increasing Focus on Emerging Markets
2.MARKET TRENDS
Pharmaceutical Industry Fares Relatively Well During Recession
Fallout of Recession on the Pharmaceutical Market – Largely an Indirect Effect
Patent Cliff Hurts Pharma Industry, Brings Smiles on the Faces of Payers
The Patent Cliff: Select Major Drugs Going Off-Patent during 2011-2015
Cost Containment Comes as a Double Blow to the Global Pharma
Global Pharma Alters Strategy - Lays More Emphasis on Specialty Areas
Innovation Continues in R&D Methods
Aging Population – A Major Driver of Pharmaceutical Growth
Market Booming for Old Age Related Medications
Rising Prominence of Biopharmaceuticals
Select FDA-Approved Biopharmaceuticals in 2010
Biotech Future Appears Bright
Focus on OTC Drugs Rising
Manufacturers Dump Conventional Approaches to Play Safe
High Fragmentation Typifies the Global Generic Drug Sector
Significant Potential for Consolidation Activity Exists in the Generic Drug Sector
Global Majors Chart Acquisition Route in Developing Economies
Expanding Opportunities through In-Licensing
Differentiation & Innovation - Key in the Competitive Market
Virtual Techniques March Ahead
Big Pharma Companies Cashing in on the Biosimilars Drive
Biosimilar Uptake in Developed Markets Thus Far
Technologies to Gear up Research
Cloud Computing to Better Pharmaceutical Sector
Biotherapies to Drive Growth in Cancer Therapy Market
Oncology Drugs – the Leader in the Global Pharma Pipeline
Vaccine Demand on the Rise
China and India Emerge as Major Contract Manufacturing Hubs
Global Analgesics Market to Soar
Nano-Enabled Drug Discovery Geared to Lead
Proteomics – The Current Spotlight
Neurodegeneration Treatments Identified in Research
3.MAJOR ISSUES/CHALLENGES
Horde of Issues Bog Down Global Pharma Industry
Challenges Abound in OTC Business for the Pharma Industry
High Cost of Pharmaceuticals Challenge Large Scale Adoption
Regulatory Pressures – A Bone of Contention
Big Pharma R&D Pipelines are Drying Up
Legal and Infrastructure Hurdles in Emerging Markets – A Concern for Global Pharma Industry
4.COMPETITIVE LANDSCAPE
Consolidation Activity Remains Rife
Leading Pharma Companies
Major Products
5.MERGERS AND ACQUISITIONS ACTIVITY IN THE PHARMA INDUSTRY
6.STRATEGIC CORPORATE DEVELOPMENTS
7.STRATEGIC CORPORATE DEVELOPMENTS IN THE RECENT PAST
8.PRODUCT APPROVALS/LAUNCHES
A REGIONAL MARKET PERSPECTIVE
1.THE UNITED STATES
US Market Outlook
Recession Impacts US Pharma Industry
Generic Drugs Dominate in Prescriptions, Share Still Languish in Value
Biopharmaceuticals – The New Rage for US Pharma
Biopharmaceutical R&D Expenditure Stays Positive; Loses Pace
FDA Approvals Rise after Prolonged Stagnancy
Select Major New Drugs Approved by FDA in 2011
Select Major New Drugs Approved by FDA in 2010
What Lies Ahead of the Pharma Industry in the Wake of Increasing Stress?
Drug Shortages Pose Enormous Challenges
US Biopharmaceutical Industry – R&D and Trade
Medicare – The Leading Expenditure Coverage Source in the US
Competitive Scenario
Leading Products
Pharmaceutical Distribution
2.CANADA
Canadian Pharmaceutical Market to Grow Steadily
Canadian Pharmaceutical Industry – An Overview
Retail Prescriptions Rise in Canada
Generic Drugs Continue to Capture Higher Market Share
Pharmaceutical Spending Reaches Calamitous Levels in Canada
Is Excessive Supply a Cause of Higher Drug Spending in Canada?
Regulations on Generic Drugs in Canada
Key Statistics
3.JAPAN
Market Overview
Horde of Factors Result in Japanese Pharma Market Slowdown
Industry Endeavors to Catch up with Generic Fervor
New Initiatives in 2010 Drug Price Revision
Companies Struggle for Profitability amid Patent Expirations
Sluggish Domestic Demand Forces Japanese Companies to Seek Overseas Opportunities
Japanese Government Presses for Increased Use of Generic Drugs
Competition
The Mergers and Acquisitions in the Industry
Major Acquisitions of Japanese Pharmaceutical Companies: 2007-2011
4.EUROPE
European Countries Gear Up for Cost Containment Measures
4A.FRANCE
The French Pharmaceutical Market - An Overview
Measures in Place to Promote Cost Containment
Austerity Measures to Trim Pharmaceutical Market Size
4B.GERMANY
German Market Continues to Rise
Germany Mulls Over Various Cost Cutting Measures
4C.ITALY
Italian Pharmaceuticals Sector Dogged by Various Factors
Government Support Key for Growth of Innovation
Mid-Sized Firms: to Rise in Prominence
4D.THE UNITED KINGDOM
Planned Cost Cuts to Suppress Growth
Is UK’s Pharma R&D Strength in Danger?
Pfizer Continues to Rule the UK Pharmaceutical Market
4E.SPAIN
Cost-Containment Measures to Drub Market Growth
Patented Drugs Dominate the Market
Spanish Government Votes for Generic Drugs
Pharmaceutical Expenditure Continues to Plummet
Reference Pricing in Spain Meets Tremendous Success
4F.SWITZERLAND
Swiss Pharmaceutical Market to Post Steady Growth
Generics Lie Low in Swiss Pharma Industry
Swiss Pharma Industry – A Major Global Exporter of Pharmaceuticals
Appreciation of Swiss Franc Raises Concerns
4G.RUSSIA
New Insurance Scheme to Drive Market
New Laws Expand Government’s Role in Pricing
Competition Remains High
Generic Drugs to Gain Rapid Uptake in Russia
Domestic Industry Emphasizes on Generic Drugs
4H.DENMARK
Pharmaceutical Spending Rises
4I.FINLAND
Aging Population Drives Finnish Pharmaceutical Market
4J.THE NETHERLANDS
Pricing Pressures Haunt Dutch Pharmaceuticals Market
4K.LITHUANIA
Imports – A Major Source of Pharmaceuticals in Lithuania
Private Share in Pharma Expenditure Soars
4L.NORWAY
Generics Begin to Gain Momentum
4M.KAZAKHSTAN
Kazakhstan’s Pharma Market to Post Robust Growth
4N.SERBIA
Serbian Pharmaceuticals Market Challenged by Several Factors
4O.PORTUGAL
Uncertain Economic Conditions Mar Pharmaceuticals Sector in Portugal
4P.POLAND
Polish Pharmaceutical Market to Witness Substantial Growth
4Q.HUNGARY
Hungary’s Pharmaceutical Sector on the Rise
4R.GREECE
Payment Woes Compel Drug Companies to Demand Cash-on-Delivery
5.ASIA-PACIFIC
Asia-Pacific – The Fastest Growing Regional Market for Pharmaceuticals Worldwide
Access to Pharmaceuticals – A Major Impediment to Asian Pharma Market Growth
Lipitor – The Leading Brand in the Asia-Pacific Pharmaceutical Market
5A.CHINA
Chinese Pharmaceutical Market Posts Remarkable Growth
Economic Growth Drives Pharmaceutical Expenditure
Chinese Pharmaceutical Industry Makes a Mark for Itself
Industry Outlook Remains Robust
Government Increases Industry Scrutiny
Chinese Pharmaceutical Industry Surges amid Recession
A Strong, Innovative Pharmaceutical Industry in the Making
Increasing Opportunities for Multinational Companies in China
Chinese Company Makes Foray into the US
Chinese CRO Market Grows at a Robust Pace
Government Investments Imperative to Realize Strong Industry Growth
Big MNCs Eye Chinese Pharmaceutical Industry
Major Challenges
Government’s Pricing Reforms Puts Multinational Pharma Companies in a Quandary
China Faces New Challenges and Short- Term Risks
Stringent Government Regulations Affects China’s Pharmaceutical Industry
Essential Drugs and Primary Healthcare Holds Discouraging Prospects for Multinational Pharma Companies
5B.AUSTRALIA
Tough Economic Environment Hits Pharmaceutical Market
Market Drivers Remain Intact
Changes to PBS set to Result in Dramatic Changes in the Market
5C.INDIA
Indian Pharma Market to Surge
Generics Lead the Market
Biopharmaceutical Segment Registers Strong Growth
Diabetes and Cancer Segments-To Lead Growth
Rapid Growth Ahead in the Indian Pharmaceutical Industry
Indian Generic Drug Producers to See High Demand from the US
India API Producers Eye Japanese Market
Government Offers Ample Support for Foreign Investment
Overseas Pharma Companies Follow Indian Counterparts to Gain Market Share
Collaborations and Consolidation – A Major Strategy for India Pharma Giants
Mergers and Acquisitions Dominate the Market Scenario
Major Acquisitions of Indian Pharmaceutical Companies/Businesses in Recent Years
Cipla Tops Indian Pharmaceutical Market by Value
Cough Medication Tops Indian Pharmaceutical Sales Chart
India Leads in DMF Filings in the US
5D.SOUTH KOREA
Exports of Pharmaceutical Products Surge, Imports Remain Far Ahead
Government Sees Pharma as the Next Growth Engine (Korea)
Government Support, Key for Growth of Innovation
Clinical Trials Flourish in Korea
Plavix Stands Ahead of Lipitor in Korea
5E.THE PHILIPPINES
Pharmaceutical Market in the Philippines to Surge
Consolidation within the Pharmaceutical Sector on the Cards
5F.THAILAND
Generics – A Dominant Segment in the Thai Pharmaceutical Market
Thailand – A Growing Domestic Market for Pharmaceuticals
5G.MALAYSIA
Low Per-Capita Consumption Typifies Malaysian Pharmaceutical Market
Market Bodes Tremendous Growth Prospects
Generics Dominate the Domestic Pharmaceutical Sector
A Peek into the Malaysian Pharmaceutical Industry
Major Drugs
5H.PAKISTAN
Relatively Stable Environment to Surge Demand for Pharma Products
Pakistan – Still Not A Favorite Destination for Global Pharma
Exports Continue to Rise, Trade Balance Remains Negative
Lack of Price Revision – A Major Cause of Concern for Domestic Industry
High Government’s Share in Healthcare Spending Curbs Drug Price Growth
Changing Government’s View on Reimbursements to Offer Respite to Market Growth
5I.VIETNAM
Growth Abounds in the Vietnamese Pharmaceutical Market
Increasing Drug Prices Leave Bitter Taste Among Patients
Vietnamese Pharmaceutical Market Fares Well During Recession
Industry Depends Immensely on Imports
Commitment to WTO Opens Vietnamese Market for Foreign Players
Pharmaceutical Imports Continue to Rise
5J.SRI LANKA
Sri Lankan Pharmaceutical Market – Going Strong
High Reliance on Imports – A Cause of Concern to the Industry
5K.SINGAPORE
Singapore – More Promising for Pharmaceutical Research Segment
Roche’s Products Lead Singapore’s Pharmaceutical Market
5L.INDONESIA
Overseas Companies Lose Ground in Indonesian Pharmaceutical Industry
6.LATIN AMERICA
Latin American Pharmaceutical Market Surges Ahead
Generic Drug Market Picking Up in Latin America
6A.BRAZIL
Foreign Manufacturers Storm into Brazilian Pharmaceutical Sector
6B.ARGENTINA
Argentinean Pharmaceutical Market to Post Robust Growth
A Strong Domestic Industry Supports Argentinean Pharmaceutical Market
6C.VENEZUELA
Market Overview
6D.MEXICO
Host of Factors to Restrain Future Growth in Market
6E.CHILE
Chilean Pharmaceutical Sector – A Snapshot
6F.COLOMBIA
Market Overview & Outlook
6G.PERU
Market Overview
6H.CUBA
Cuban Pharmaceutical Market – The Smallest in the Region
7.REST OF WORLD
Middle East and Africa Augurs Huge Growth Prospects for Global Pharmaceutical Industry
Diverse Healthcare Systems in the MEA Region
Multinational Companies Flock MEA Region
Overview of Middle East Pharmaceutical Market
7A.SAUDI ARABIA
Saudi Arabia – A Lucrative Market in the Region
Generic Drugs – A Major Focus of the Domestic Industry
Presence of Overseas Players Increases in the Saudi Pharmaceutical Industry
Pharmaceutical Exports on the Rise
Industry Battles Issues
7B.UNITED ARAB EMIRATES
A Glimpse of UAE Pharmaceutical Industry
Investments Remain a Lackluster Affair
Major Players
Recent Events Tighten Manufacturers’ Profitability
7C.EGYPT
Overview
7D.JORDAN
Overview
7E.MOROCCO
Overview
7F.TURKEY
Overview
7G.OMAN
Overview
Global Directory
Global Pharmaceutical Market – Hit, but Not Down
Cost Containment and Patent Expirations Affect Market Growth
Industry Seeks Measures to Sustain Future Growth
Outlook Remains Positive, Yet Tempered
Table 1. World Recent Past, Current & Future Analysis for Prescription Pharmaceutical Market by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin American and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Billion for Years 2010 through 2015
Table 2. World 5-Year Perspective for Prescription Pharmaceuticals by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2011 and 2015
Oncologics – The Largest Drug Class in the Global Prescription Pharmaceutical Market
Table 3. World Recent Past, Current & Future Analysis for Prescription Pharmaceuticals by Therapeutic Class – Angiotensin II Antagonists, Antidepressants, Antidiabetics, Anti-epileptics, Antipsychotics, Anti-ulcerants, Autoimmune agents, Lipid Regulators, Oncologics, Respiratory Agents and Others Markets Independently Analyzed with Annual Sales Figures in US$ Billion for Years 2010 through 2015
Table 4. World 5-Year Perspective for Prescription Pharmaceuticals by Therapeutic Class - Percentage Breakdown of Dollar Sales for Angiotensin II Antagonists, Antidepressants, Antidiabetics, Anti-epileptics, Antipsychotics, Anti-ulcerants, Autoimmune agents, Lipid Regulators, Oncologics, Respiratory Agents and Others Markets for Years 2011 and 2015
Major Challenges Faced by the Global Pharma Industry
Key Opportunities
Generic Drug Sales Soar
Authorized Generics – A Major Concern for Generic Makers
Increasing Focus on Emerging Markets
2.MARKET TRENDS
Pharmaceutical Industry Fares Relatively Well During Recession
Fallout of Recession on the Pharmaceutical Market – Largely an Indirect Effect
Patent Cliff Hurts Pharma Industry, Brings Smiles on the Faces of Payers
The Patent Cliff: Select Major Drugs Going Off-Patent during 2011-2015
Cost Containment Comes as a Double Blow to the Global Pharma
Global Pharma Alters Strategy - Lays More Emphasis on Specialty Areas
Innovation Continues in R&D Methods
Aging Population – A Major Driver of Pharmaceutical Growth
Market Booming for Old Age Related Medications
Rising Prominence of Biopharmaceuticals
Select FDA-Approved Biopharmaceuticals in 2010
Biotech Future Appears Bright
Focus on OTC Drugs Rising
Manufacturers Dump Conventional Approaches to Play Safe
High Fragmentation Typifies the Global Generic Drug Sector
Table 5. Leading Companies in the Global Generic Drugs Market (2010): Percentage Breakdown by Value Sales for Teva Pharmaceutical Industries, Sandoz, Mylan Laboratories, Watson, Ratiopharm, and Others
Significant Potential for Consolidation Activity Exists in the Generic Drug Sector
Global Majors Chart Acquisition Route in Developing Economies
Expanding Opportunities through In-Licensing
Differentiation & Innovation - Key in the Competitive Market
Virtual Techniques March Ahead
Big Pharma Companies Cashing in on the Biosimilars Drive
Biosimilar Uptake in Developed Markets Thus Far
Technologies to Gear up Research
Cloud Computing to Better Pharmaceutical Sector
Biotherapies to Drive Growth in Cancer Therapy Market
Oncology Drugs – the Leader in the Global Pharma Pipeline
Vaccine Demand on the Rise
China and India Emerge as Major Contract Manufacturing Hubs
Global Analgesics Market to Soar
Nano-Enabled Drug Discovery Geared to Lead
Proteomics – The Current Spotlight
Neurodegeneration Treatments Identified in Research
3.MAJOR ISSUES/CHALLENGES
Horde of Issues Bog Down Global Pharma Industry
Challenges Abound in OTC Business for the Pharma Industry
High Cost of Pharmaceuticals Challenge Large Scale Adoption
Regulatory Pressures – A Bone of Contention
Big Pharma R&D Pipelines are Drying Up
Legal and Infrastructure Hurdles in Emerging Markets – A Concern for Global Pharma Industry
4.COMPETITIVE LANDSCAPE
Consolidation Activity Remains Rife
Table 6. Global Pharmaceutical M&A Activity in Transaction Volume by Country/Region: 2010
Table 7. Global Pharmaceutical M&A Activity in Transaction Value by Country: 2010
Table 8. Global M&A Activity by Therapeutic Area (2010): Percentage Breakdown of Number of Deals for Oncology, Cardiovascular, Central Nervous System, Dermatology, Gastro-Intestinal and Others
Table 9. Select Acquisitions in the Pharmaceutical Industry Worldwide: 2011
Table 10. Select Acquisitions in the Pharmaceutical Industry Worldwide: 2010
Leading Pharma Companies
Table 11. Leading Pharmaceutical Manufacturers Worldwide by Revenues: 2009 & 2010
Major Products
Table 12. Leading Pharmaceutical Products Worldwide by Sales: 2009 & 2010
5.MERGERS AND ACQUISITIONS ACTIVITY IN THE PHARMA INDUSTRY
6.STRATEGIC CORPORATE DEVELOPMENTS
7.STRATEGIC CORPORATE DEVELOPMENTS IN THE RECENT PAST
8.PRODUCT APPROVALS/LAUNCHES
A REGIONAL MARKET PERSPECTIVE
1.THE UNITED STATES
US Market Outlook
Recession Impacts US Pharma Industry
Generic Drugs Dominate in Prescriptions, Share Still Languish in Value
Table 13. Leading Companies in the US Generic Drugs Market (2010): Percentage Breakdown by Value Sales for Teva Pharmaceutical Industries, Mylan Laboratories, Watson, Sandoz, Mallinckrodt and Others
Biopharmaceuticals – The New Rage for US Pharma
Biopharmaceutical R&D Expenditure Stays Positive; Loses Pace
Table 14. R&D Expenditure In the US Pharmaceutical Industry: 2006-2010
FDA Approvals Rise after Prolonged Stagnancy
Select Major New Drugs Approved by FDA in 2011
Select Major New Drugs Approved by FDA in 2010
What Lies Ahead of the Pharma Industry in the Wake of Increasing Stress?
Drug Shortages Pose Enormous Challenges
US Biopharmaceutical Industry – R&D and Trade
Table 15. US Exports of Biopharmaceuticals: 2005-2010
Medicare – The Leading Expenditure Coverage Source in the US
Table 16. Prescription Drug Expenditure in the US by Payer (2005 & 2010): Percentage Breakdown of Expenditure for Medicare, Medicaid and Others
Competitive Scenario
Table 17. Leading Pharmaceutical Companies in the US by Prescription Drug Revenue: 2009 & 2010
Table 18. Leading Pharmaceutical Companies in the US by Total Prescriptions: 2009 & 2010
Leading Products
Table 19. Leading Prescription Drugs in the US by Value Sales: 2009 & 2010
Table 20. Leading Prescription Drugs in the US by Dispensed Prescriptions: 2009 & 2010
Table 21. Leading Generic Drugs in the US by Total Prescriptions: 2010
Table 22. Leading Brands in the US Eye/Lens Care Solutions Market by Value Sales at Drug Stores: 2009
Table 23. Leading Brands in the US Eye/Lens Care Solutions Market by Unit Sales at Drug Stores: 2009
Pharmaceutical Distribution
Table 24. US Prescription Pharmaceutical Market by Distribution Channel (2009 & 2010): Percentage Breakdown of Revenues for Chain Stores, Mail Service, Independent Stores, Clinics, Private Hospitals and Others
Table 25. US Prescription Pharmaceutical Market by Distribution Channel (2009 & 2010): Percentage Breakdown of Total Prescriptions for Chain Stores, Independent Stores, Food Stores and Others
2.CANADA
Canadian Pharmaceutical Market to Grow Steadily
Canadian Pharmaceutical Industry – An Overview
Retail Prescriptions Rise in Canada
Generic Drugs Continue to Capture Higher Market Share
Pharmaceutical Spending Reaches Calamitous Levels in Canada
Table 26. Share of Expenditure on Drugs in the Total Canadian Healthcare Expenditure (1975-2010)
Is Excessive Supply a Cause of Higher Drug Spending in Canada?
Regulations on Generic Drugs in Canada
Key Statistics
Table 27. Leading Therapeutic Classes in the Canadian Pharmaceutical Market by Total Prescriptions: 2008-2010
Table 28. Leading Drugs in the Canadian Pharmaceutical Market by Total Prescriptions: 2008 & 2009
Table 29. Leading Companies in the Canadian Pharmaceutical Market by Revenue: 2008 & 2009
3.JAPAN
Market Overview
Horde of Factors Result in Japanese Pharma Market Slowdown
Industry Endeavors to Catch up with Generic Fervor
New Initiatives in 2010 Drug Price Revision
Table 30. Japanese Generic Drug Market by Revenues: 2007-2011
Companies Struggle for Profitability amid Patent Expirations
Sluggish Domestic Demand Forces Japanese Companies to Seek Overseas Opportunities
Japanese Government Presses for Increased Use of Generic Drugs
Competition
The Mergers and Acquisitions in the Industry
Major Acquisitions of Japanese Pharmaceutical Companies: 2007-2011
4.EUROPE
European Countries Gear Up for Cost Containment Measures
Table 31. European Recent Past, Current & Future Analysis for Prescription Pharmaceuticals by Geographic Region – France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Billion for Years 2010 through 2015
Table 32. European 5-Year Perspective for Prescription Pharmaceuticals by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain and Rest of Europe Markets for Years 2011 and 2015
4A.FRANCE
The French Pharmaceutical Market - An Overview
Measures in Place to Promote Cost Containment
Austerity Measures to Trim Pharmaceutical Market Size
4B.GERMANY
German Market Continues to Rise
Germany Mulls Over Various Cost Cutting Measures
Table 33. German Pharmaceutical Production by Value: 2001-2010
4C.ITALY
Italian Pharmaceuticals Sector Dogged by Various Factors
Government Support Key for Growth of Innovation
Mid-Sized Firms: to Rise in Prominence
4D.THE UNITED KINGDOM
Planned Cost Cuts to Suppress Growth
Is UK’s Pharma R&D Strength in Danger?
Pfizer Continues to Rule the UK Pharmaceutical Market
Table 34. Percentage Share Breakdown of Sales in the UK Pharmaceutical Market by Leading Players: 2010
4E.SPAIN
Cost-Containment Measures to Drub Market Growth
Patented Drugs Dominate the Market
Table 35. Spanish Pharmaceutical Market by Segment (2010): Percentage Breakdown of Sales for Patent-Protected Drugs, OTC Drugs and Generic Drugs
Spanish Government Votes for Generic Drugs
Pharmaceutical Expenditure Continues to Plummet
Reference Pricing in Spain Meets Tremendous Success
4F.SWITZERLAND
Swiss Pharmaceutical Market to Post Steady Growth
Generics Lie Low in Swiss Pharma Industry
Swiss Pharma Industry – A Major Global Exporter of Pharmaceuticals
Appreciation of Swiss Franc Raises Concerns
4G.RUSSIA
New Insurance Scheme to Drive Market
New Laws Expand Government’s Role in Pricing
Competition Remains High
Generic Drugs to Gain Rapid Uptake in Russia
Domestic Industry Emphasizes on Generic Drugs
4H.DENMARK
Pharmaceutical Spending Rises
4I.FINLAND
Aging Population Drives Finnish Pharmaceutical Market
4J.THE NETHERLANDS
Pricing Pressures Haunt Dutch Pharmaceuticals Market
4K.LITHUANIA
Imports – A Major Source of Pharmaceuticals in Lithuania
Private Share in Pharma Expenditure Soars
4L.NORWAY
Generics Begin to Gain Momentum
4M.KAZAKHSTAN
Kazakhstan’s Pharma Market to Post Robust Growth
4N.SERBIA
Serbian Pharmaceuticals Market Challenged by Several Factors
4O.PORTUGAL
Uncertain Economic Conditions Mar Pharmaceuticals Sector in Portugal
4P.POLAND
Polish Pharmaceutical Market to Witness Substantial Growth
4Q.HUNGARY
Hungary’s Pharmaceutical Sector on the Rise
4R.GREECE
Payment Woes Compel Drug Companies to Demand Cash-on-Delivery
5.ASIA-PACIFIC
Asia-Pacific – The Fastest Growing Regional Market for Pharmaceuticals Worldwide
Table 36. Asia-Pacific Recent Past, Current & Future Analysis for Prescription Pharmaceuticals by Geographic Region – China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Billion for Years 2010 through 2015
Table 37. Asia-Pacific 5-Year Perspective for Prescription Cards by Geographic Region - Percentage Breakdown of Dollar Sales for China, India and Rest of Asia- Pacific Markets for Years 2011 and 2015
Access to Pharmaceuticals – A Major Impediment to Asian Pharma Market Growth
Lipitor – The Leading Brand in the Asia-Pacific Pharmaceutical Market
Table 38. Leading Pharmaceutical Products in Asia by Revenue: 2009
5A.CHINA
Chinese Pharmaceutical Market Posts Remarkable Growth
Economic Growth Drives Pharmaceutical Expenditure
Chinese Pharmaceutical Industry Makes a Mark for Itself
Industry Outlook Remains Robust
Government Increases Industry Scrutiny
Chinese Pharmaceutical Industry Surges amid Recession
A Strong, Innovative Pharmaceutical Industry in the Making
Increasing Opportunities for Multinational Companies in China
Chinese Company Makes Foray into the US
Chinese CRO Market Grows at a Robust Pace
Government Investments Imperative to Realize Strong Industry Growth
Big MNCs Eye Chinese Pharmaceutical Industry
Major Challenges
Government’s Pricing Reforms Puts Multinational Pharma Companies in a Quandary
China Faces New Challenges and Short- Term Risks
Stringent Government Regulations Affects China’s Pharmaceutical Industry
Essential Drugs and Primary Healthcare Holds Discouraging Prospects for Multinational Pharma Companies
5B.AUSTRALIA
Tough Economic Environment Hits Pharmaceutical Market
Market Drivers Remain Intact
Changes to PBS set to Result in Dramatic Changes in the Market
Table 39. Leading Pharmaceutical Products in Australia by Revenue: 2009
5C.INDIA
Indian Pharma Market to Surge
Generics Lead the Market
Biopharmaceutical Segment Registers Strong Growth
Diabetes and Cancer Segments-To Lead Growth
Rapid Growth Ahead in the Indian Pharmaceutical Industry
Indian Generic Drug Producers to See High Demand from the US
India API Producers Eye Japanese Market
Government Offers Ample Support for Foreign Investment
Overseas Pharma Companies Follow Indian Counterparts to Gain Market Share
Collaborations and Consolidation – A Major Strategy for India Pharma Giants
Mergers and Acquisitions Dominate the Market Scenario
Major Acquisitions of Indian Pharmaceutical Companies/Businesses in Recent Years
Cipla Tops Indian Pharmaceutical Market by Value
Table 40. Leading Indian Pharmaceutical Companies by Domestic Sales: 2010
Cough Medication Tops Indian Pharmaceutical Sales Chart
Table 41. Leading Pharmaceutical Products in India by Revenue: 2009
India Leads in DMF Filings in the US
Table 42. Leading DMF Filing Countries with the US FDA: 2009
5D.SOUTH KOREA
Exports of Pharmaceutical Products Surge, Imports Remain Far Ahead
Government Sees Pharma as the Next Growth Engine (Korea)
Government Support, Key for Growth of Innovation
Clinical Trials Flourish in Korea
Table 43. South Korean Clinical Trial Market by Number of IND Applications Approved by Korean Food and Drug Administration
Plavix Stands Ahead of Lipitor in Korea
Table 44. Leading Pharmaceutical Products in Korea by Revenue: 2009
5E.THE PHILIPPINES
Pharmaceutical Market in the Philippines to Surge
Consolidation within the Pharmaceutical Sector on the Cards
5F.THAILAND
Generics – A Dominant Segment in the Thai Pharmaceutical Market
Thailand – A Growing Domestic Market for Pharmaceuticals
5G.MALAYSIA
Low Per-Capita Consumption Typifies Malaysian Pharmaceutical Market
Market Bodes Tremendous Growth Prospects
Generics Dominate the Domestic Pharmaceutical Sector
A Peek into the Malaysian Pharmaceutical Industry
Major Drugs
Table 45. Leading Pharmaceutical Products in Malaysia by Revenue: 2009
5H.PAKISTAN
Relatively Stable Environment to Surge Demand for Pharma Products
Pakistan – Still Not A Favorite Destination for Global Pharma
Exports Continue to Rise, Trade Balance Remains Negative
Lack of Price Revision – A Major Cause of Concern for Domestic Industry
High Government’s Share in Healthcare Spending Curbs Drug Price Growth
Changing Government’s View on Reimbursements to Offer Respite to Market Growth
5I.VIETNAM
Growth Abounds in the Vietnamese Pharmaceutical Market
Increasing Drug Prices Leave Bitter Taste Among Patients
Vietnamese Pharmaceutical Market Fares Well During Recession
Industry Depends Immensely on Imports
Commitment to WTO Opens Vietnamese Market for Foreign Players
Pharmaceutical Imports Continue to Rise
5J.SRI LANKA
Sri Lankan Pharmaceutical Market – Going Strong
High Reliance on Imports – A Cause of Concern to the Industry
5K.SINGAPORE
Singapore – More Promising for Pharmaceutical Research Segment
Roche’s Products Lead Singapore’s Pharmaceutical Market
Table 46. Leading Pharmaceutical Products in Singapore by Revenue: 2009
5L.INDONESIA
Overseas Companies Lose Ground in Indonesian Pharmaceutical Industry
6.LATIN AMERICA
Latin American Pharmaceutical Market Surges Ahead
Generic Drug Market Picking Up in Latin America
6A.BRAZIL
Foreign Manufacturers Storm into Brazilian Pharmaceutical Sector
6B.ARGENTINA
Argentinean Pharmaceutical Market to Post Robust Growth
A Strong Domestic Industry Supports Argentinean Pharmaceutical Market
6C.VENEZUELA
Market Overview
6D.MEXICO
Host of Factors to Restrain Future Growth in Market
6E.CHILE
Chilean Pharmaceutical Sector – A Snapshot
6F.COLOMBIA
Market Overview & Outlook
6G.PERU
Market Overview
6H.CUBA
Cuban Pharmaceutical Market – The Smallest in the Region
7.REST OF WORLD
Middle East and Africa Augurs Huge Growth Prospects for Global Pharmaceutical Industry
Diverse Healthcare Systems in the MEA Region
Multinational Companies Flock MEA Region
Overview of Middle East Pharmaceutical Market
7A.SAUDI ARABIA
Saudi Arabia – A Lucrative Market in the Region
Generic Drugs – A Major Focus of the Domestic Industry
Presence of Overseas Players Increases in the Saudi Pharmaceutical Industry
Pharmaceutical Exports on the Rise
Industry Battles Issues
7B.UNITED ARAB EMIRATES
A Glimpse of UAE Pharmaceutical Industry
Investments Remain a Lackluster Affair
Major Players
Recent Events Tighten Manufacturers’ Profitability
7C.EGYPT
Overview
7D.JORDAN
Overview
7E.MOROCCO
Overview
7F.TURKEY
Overview
7G.OMAN
Overview
Global Directory
